Changes in Management Of Karo Bio AB
19-Aug-2011
- Sweden
Acting President and CEO Per Bengtsson will temporarily assume management responsibility for clinical development and regulatory affairs until a new Chief Medical Officer has been recruited. The change in management will not affect the clinical development plan of eprotirome.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
Last viewed contents
BBCH-scale_(beet)
Go to page
Schizophrenia
Go to page
DIENES Apparatebau GmbH - Mühlheim am Main, Germany
Go to page
Binder Edelstahl Produktionsges.mbH - Bremen, Germany
Go to page
BBCH-scale_(canola)
Go to page
DINOTEC GmbH Wassertechnologie und Schwimmbadtechnik - Maintal, Germany
Go to page
Hering Bau GmbH & Co. KG - Burbach, Germany
Go to page
Röltgen GmbH & Co. KG - Solingen, Germany
Go to page
Cyano Biofuels GmbH - Berlin, Germany
Go to page
BBCH-scale_(bean)
Go to page
CEITEC Cluster - bioinformatics - Brünn, Czechia
Go to page
dievini Hopp BioTech holding GmbH & Co. KG - Walldorf, Germany
Go to page